CISGEM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CISGEM, covering 2025-08-17 to 2025-08-17. Get the full timeline:
Most recent: Clinical Trial Update: PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma [Phase 2]